Front Aging Neurosci
September 2024
What Is Known And Objective: Patients with kidney disease receiving immunosuppressive drugs (ISDs) (tacrolimus, cyclosporine and glucocorticoids) have a high risk of developing new-onset diabetes mellitus (NODM). We aimed to establish a precise and convenient model for predicting NODM in patients receiving immunosuppressive drugs.
Methods: This retrospective study recruited 1883 patients receiving ISDs between January 2010 and October 2018.
5-Methoxytryptophan (5-MTP) is a tryptophan metabolite with recently discovered anti-inflammatory and tumor-suppressing activities. Its synthesis is catalyzed by a hydroxyindole -methyltransferase (HIOMT)-like enzyme. However, the exact identity of this HIOMT in human cells remains unclear.
View Article and Find Full Text PDF